🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
The primary objective of the two phase PERMAD trial is the evaluation of th...
Status
Unknown
Location
University Medical Center Hamburg-Eppendorf
Start Date
2015-03
Trial ID
NCT02331927
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of mFOLFOX6+be...
Status
Completed
Location
EPS Corporation
Start Date
2013-05
Trial ID
NCT01836653
This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2019-08-29
Trial ID
NCT03929666
This study will compare the safety and efficacy of sunitinib in combination...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2008-04
Trial ID
NCT00609622
Treatments Being Tested
The purpose of this study is to verify the efficacy of mFOLFOX6 + panitumum...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-29
Trial ID
NCT02394795
The purpose of this study is to compare OnDose® based pharmacokinetic admin...
Status
Terminated
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01468623
Treatments Being Tested
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
This randomized phase II trial studies how well combination chemotherapy an...
Status
Withdrawn
Location
USC Norris Comprehensive Cancer Center
Start Date
2015-11
Trial ID
NCT02413853
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
START Midwest/Cancer & Hematology Centers of Western Michigan, PC
Start Date
2015-10
Trial ID
NCT02648711
Treatments Being Tested